Alumna startup Aluna acquired by Huma

photo of person using Aluna device

Aluna, a company spun out of an undergraduate capstone project by alumna Charvi Shetty, has been acquired by Huma. Aluna developed an easy and fun remote monitoring system for respiratory diseases, which will now be able to reach patients in Huma’s more than 150 U.S. health systems, serving over 500,000 people.

Read More

UC Berkeley Awards $200K Venture Grant to HypO2Regen Therapeutics

text logo of HypO2Regen Therapeutics

Professor Phil Messersmith and colleagues have launched HypO2Regen Therapeutics, a startup developing novel, disease-modifying therapeutics for chronic intractable inflammatory diseases, including the first cell-free stem cell treatment that induces true regeneration of damaged tissue. Their first effort takes aim at periodontitis, which affects over 300 million people worldwide.

Read More

The booming business of discovering your biological age

Conboy photo

Professor Irina Conboy and former student Alina Su have founded a new company, Generation Lab, offering an at-home molecular aging test that analyzes a person’s biological age by assessing “biological noise” in their system. The test evaluates an individual’s risk for top health conditions and the pace of aging across 19 systems in the body, which can help physicians see where interventions may be most needed and effective.

Read More

Aluna named Tech for Global Good Laureate

photo of person using Aluna device

BioE startup Aluna, founded by alumna Charvi Shetty, has been named a 2023-24 Tech for Global Good Laureate, one of four venures recognized for using technology to significantly advance health equity and improve lives. Aluna makes hardware and software that helps people with breathing problems.

Read More

Bolt Threads going public

Photo of Bolt Threads cofounders Dan Widmaier (left) and David Breslauer in their manufacturing facility

Bolt Threads, a company co-founded by BioE PhD alumnus David Breslauer, plans to go public in a SPAC deal that values the one-time unicorn at $250 million. Bolt Threads uses synthetic biology and other techniques to sustainably produce engineered biomaterials, including synthetic spider silk and mushroom-based faux leather.

Read More